These experimental findings have raised concerns regarding a potential association between GLP-1 receptor agonists and C-cell hyperplasia and MTC (DrostenM et al., 2004; Gallel et al., 2008; Li et al., 2023). Here, GLP1R is linked to medullary thyroid gland carcinoma.